- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective is to evaluate the safety of ReFacto AF in previously untreated patients less than 6 years of age.
Critère d'inclusion
- Severe hemophilia A (FVIII:C <1%) in male subjects <6 years of age. Hemofilia A severa (FVIII:C<1%) en sujetos pediátricos menores de seis años de edad